Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief Scientific Officer
-
Stock Symbol
-
NTLA on Nasdaq
Laura Sepp-Lorenzino - trading volume in the past year for Intellia Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
77.4K |
$943K |
$12.18 |
Jan 3, 2025 |
Direct |
|
|
| Stock Option (right to buy) |
54.8K |
|
|
Mar 1, 2024 |
Direct |
Common Stock |
|
| Restricted Stock Unit |
0 |
|
|
Jan 1, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.